Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $520.84 million. The enterprise value is $428.93 million.
Important Dates
The next confirmed earnings date is Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 205.05 million shares outstanding. The number of shares has increased by 64.21% in one year.
| Current Share Class | 205.05M |
| Shares Outstanding | 205.05M |
| Shares Change (YoY) | +64.21% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 13.23% |
| Owned by Institutions (%) | 62.86% |
| Float | 129.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 71.14 |
| Forward PS | 70.94 |
| PB Ratio | 6.79 |
| P/TBV Ratio | 8.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 59.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.35, with a Debt / Equity ratio of 1.08.
| Current Ratio | 5.35 |
| Quick Ratio | 5.17 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -909.91 |
Financial Efficiency
Return on equity (ROE) is -159.34% and return on invested capital (ROIC) is -45.53%.
| Return on Equity (ROE) | -159.34% |
| Return on Assets (ROA) | -35.91% |
| Return on Invested Capital (ROIC) | -45.53% |
| Return on Capital Employed (ROCE) | -72.29% |
| Revenue Per Employee | $98,959 |
| Profits Per Employee | -$1.19M |
| Employee Count | 73 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.89% in the last 52 weeks. The beta is 0.88, so TSHA's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | -3.89% |
| 50-Day Moving Average | 1.73 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 66.05 |
| Average Volume (20 Days) | 3,492,049 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSHA had revenue of $7.22 million and -$86.77 million in losses. Loss per share was -$0.34.
| Revenue | 7.22M |
| Gross Profit | 7.22M |
| Operating Income | -83.71M |
| Pretax Income | -118.01M |
| Net Income | -86.77M |
| EBITDA | -82.51M |
| EBIT | -83.71M |
| Loss Per Share | -$0.34 |
Full Income StatementBalance Sheet
The company has $116.59 million in cash and $59.55 million in debt, giving a net cash position of $57.05 million or $0.28 per share.
| Cash & Cash Equivalents | 116.59M |
| Total Debt | 59.55M |
| Net Cash | 57.05M |
| Net Cash Per Share | $0.28 |
| Equity (Book Value) | 55.06M |
| Book Value Per Share | 0.27 |
| Working Capital | 98.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$83.45 million and capital expenditures -$612,000, giving a free cash flow of -$84.06 million.
| Operating Cash Flow | -83.45M |
| Capital Expenditures | -612,000 |
| Free Cash Flow | -84.06M |
| FCF Per Share | -$0.41 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,158.80% |
| Pretax Margin | -1,201.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |